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Abstract
Background:  The effects of pulmonary arterial hypertension on brain function are not
understood, despite patients' frequent complaints of cognitive difficulties. Using clinical instruments
normally administered during standard in-person assessment of neurocognitive function in adults,
we assembled a battery of tests designed for administration over the telephone. The purpose was
to improve patient participation, facilitate repeated test administration, and reduce the cost of
research on the neuropsychological consequences of acute and chronic cardiorespiratory diseases.
We undertook this study to validate telephone administration of the tests.
Methods: 23 adults with pulmonary arterial hypertension underwent neurocognitive assessment
using both standard in-person and telephone test administration, and the results of the two
methods compared using interclass correlations.
Results: For most of the tests in the battery, scores from the telephone assessment correlated
strongly with those obtained by in-person administration of the same tests. Interclass correlations
between 0.5 and 0.8 were observed for tests that assessed attention, memory, concentration/
working memory, reasoning, and language/crystallized intelligence (p ≤  0.05 for each). Interclass
correlations for the Hayling Sentence Completion test of executive function approached
significance (p = 0.09). All telephone tests were completed within one hour.
Conclusion: Administration of this neurocognitive test battery by telephone should facilitate
assessment of neuropsychological deficits among patients with pulmonary arterial hypertension
living across broad geographical areas, and may be useful for monitoring changes in neurocognitive
function in response to PAH-specific therapy or disease progression.
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Introduction
Pulmonary arterial hypertension (PAH) is a devastating
disease characterized by progressive shortness of breath
and the eventual development of life-threatening heart
failure [1-4]. While its effects on cardiovascular function
have been well documented, little is known about effects
of this disease on other organ systems, notably the brain.
Patients frequently complain of changes in memory, con-
centration and judgment in association with the develop-
ment of cardiopulmonary symptoms[5]. Objective
assessments of cognitive function, however, have not
been performed.
The "gold standard" for comprehensive assessment of
neurocognitive function is a comprehensive battery of
individually validated tests that are administered in-per-
son by an experienced interviewer. Comprehensive,
standard testing often takes four hours or longer and may
require two or more separately scheduled sessions. The
experience can be stressful and fatiguing, particularly for
chronically ill or physically disabled patients. The stress of
additional travel to a testing site adds to the burden. Con-
sequently, many patients decline to participate in clinical
research that uses formal in-person neurocognitive test-
ing, especially if the protocol includes repeated testing
over time [6,7].
To address these concerns, we developed a focused battery
of neurocognitive tests for administration over the tele-
phone. The battery is comprised of individually validated
neurocognitive test instruments appropriate for adminis-
tration to adults with cardiopulmonary disease who are
fluent in English and capable of communicating verbally.
Telephone administration of the test battery has been
evaluated for feasibility and validity in survivors of the
acute respiratory distress syndrome [8]. The present study
establishes the validity of telephone administration of the
test battery by comparing the results of telephone testing
against "gold standard" in-person administration in adult
ambulatory patients with moderately to severely sympto-
matic PAH.
Methods
Study Population
Consecutive patients diagnosed with pulmonary arterial
hypertension according to standard criteria [2,9] were
prospectively recruited for neurocognitive testing from the
Pulmonary Hypertension Clinic at LDS Hospital. Written
informed consent was obtained from the patients for both
the in-person and telephone neuropsychological testing.
Inclusion criteria were age 18 years or older and the ability
to give informed consent. Exclusion criteria included non-
fluency in English, a history of major psychiatric illness
(e.g. schizophrenia, schizoaffective disorder, bipolar dis-
order, psychoses requiring medication and/or hospitaliza-
tion, and major depression requiring hospitalization),
known learning disability, prior traumatic brain injury,
diagnosis of dementia, cerebral vascular accident, neuro-
logic disorder (e.g. multiple sclerosis, Huntington's Dis-
ease, etc.), prior cardiac surgery, or current alcohol or drug
abuse.
Patients were recruited for neurocognitive assessment
from a group who had consented to in-person testing.
Sixty-seven patients were screened. Seventeen patients
declined, two were excluded due to non-fluency in Eng-
lish, and two were medically unstable at the time of eval-
uation and died during the recruitment period. Of the 46
patients who consented to in-person neurocognitive test-
ing, 25 consented to additional testing by telephone.
Patient demographic, medical and laboratory data were
collected for all enrolled patients. This study was
approved by the University of Pennsylvania and LDS Hos-
pital Institutional Review Boards and conformed to insti-
tutional and federal guidelines for the protection of
human subjects.
Neurocognitive Assessment
An interdisciplinary team of neuropsychology, traumatic
brain injury, rehabilitation medicine, and pulmonary dis-
ease specialists selected a battery of standardized neuro-
cognitive tests amenable to both in-person and telephone
administration. Tests were also chosen on the basis of
established sensitivity in detecting impairment in patients
with cardiopulmonary disorders and concomitant hypox-
emia [10-13]. The cognitive domains assessed and the
tests included in the battery are listed in Table 1. All neu-
rocognitive tests included in the battery have been empir-
ically validated and standardized [14-17] with established
reliability, internal and external validity[12,14,16,18,19].
The neurocognitive tests were administered in a random
sequence to minimize order effects. However, as a delay is
required between the Wechsler Memory Scale-III Logical
Memory I and II tests, Logical memory I (immediate
recall) was the first and Logical Memory II (delay recall)
the last test administered in each session.
The in-person assessment was carried out in a private
office at LDS Hospital. The identical tests were adminis-
tered subsequently by telephone at a prearranged time
when patients were at home and free from distraction. To
minimize potential learning effects, telephone testing was
performed at least 2.5 months following in-person assess-
ment, except with one patient who was tested 57 days
after in-person evaluation. A Ph.D. neuropsychologist
(ROH) administered the in-person tests and a neuropsy-
chology doctoral student administered the telephone tests
with no knowledge of the results of the previous in-person
testing. During both the in-person and telephone tests,Respiratory Research 2005, 6:39 http://respiratory-research.com/content/6/1/39
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patients were instructed not to write down information
and to answer questions without assistance. The in-person
and telephone assessments were both conducted in single
sessions, and each took 35 to 45 minutes to complete.
All neuropsychological tests were scored according to the
published guidelines. Each test yields a raw score that was
converted into a scaled score (mean = 10; SD = 3), which
was used for statistical analyses, except for Logical Mem-
ory where the raw scores are used.
Statistical Analysis
Descriptive statistics were carried out for demographic
and medical data. The neuropsychological test scores
from the in-person administration were compared to tel-
ephone test scores using interclass correlations. To facili-
tate interpretation of significant correlations (p ≤  0.05)
and because traditional significance levels for correlations
coefficients are influenced by factors such as group size,
range of scores, and multiple comparisons, we used the
following conservative classification: fair correlation with
coefficients between 0.21 and 0.40; moderate correlation
0.41 to 0.60; substantial correlation 0.61 to 0.80; and
almost perfect correlation 0.81 to 1.00 [20].
To assess potential learning effects, systematic differences
between first and second administrations for each of the
tests were assessed using paired sample t-tests. The differ-
ences between the in-person and telephone test results are
expressed as standardized effects sizes (T2-T1 differences
divided by T1 standard deviation) [21].
Results
Twenty-five patients with pulmonary arterial hyperten-
sion were enrolled for neurocognitive evaluation using
both in-person and telephone testing. All 25 patients
completed in-person testing. Telephone testing could not
be completed on one subject due to a non-functioning tel-
ephone line, and one subject died of progressive right
heart failure. All of the remaining 23 subjects completed
both the in-person and telephone assessments and were
included in the validation group. Eighty-three percent (n
= 19) of these subjects were women. The mean ± SD age
was 49.7 ± 13.9 years (range 20 to 60 years) and the mean
Table 1: Neurocognitive Battery for Telephone Administration
COGNITIVE DOMAIN TEST INSTRUMENT
Attention WMS-III: Digits Forward
Concentration/Working Memory WMS-III: Digits Backward
WMS-III: Letter-Number Sequencing
Executive Function Hayling Sentence Completion Test
Reasoning WAIS-III: Similarities
Language / Crystallized Intelligence WAIS-III Vocabulary
Memory WMS-III: Logical Memory I & II
Table 2: Demographic and Medical Data
Mean ± SD Range
Gender (% female) (n = 25) 83%
Education (years) 13.6 ± 3.0 6 to 20
Age (years) 49.7 ± 13.9 20 to 69
Time Since Diagnosis (years) 1.8 ± 1.5 0.8 to 5.3
PaO2 mmHg 62.6 ± 13.5 38 to 97
Most recent 6 minute walk (meters) 455 ± 132 227 to 877
New York Heart Functional Class (N)
Class 1 0
Class 2 3
Class 3 20
Class 4 0
Supplemental Oxygen (N)
2 Liters per minute 7
3 Liters per minute 8
4 Liters per minute 4Respiratory Research 2005, 6:39 http://respiratory-research.com/content/6/1/39
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education level was 13.6 ± 3.0 years (range 6 to 20 years).
The mean number of days between in-person and tele-
phone testing was 121.6 (range 57 to 200 days). The eti-
ology of PAH was: idiopathic ("primary") PAH in ten
patients (43%), associated with anorexigen use in six
(26%), collagen vascular disease in four (17%), congeni-
tal heart disease in two (9%) and one with portopulmo-
nary hypertension (4%). The mean (± SD) right atrial
pressure was 5.1 ± 1.8 mmHg, mean pulmonary artery
pressure 52.1 ± 16.9 and pulmonary capillary wedge pres-
sure 12.1 ± 6.2. The mean cardiac output was 5.1 ± 1.8 L/
min. Demographic and medical data are shown in Table
2.
The results of the telephone and in-person neurocognitive
assessments are shown in Table 3. The correlation coeffi-
cients for the comparison between in-person and tele-
phone testing are presented in Table 4. Interclass
correlation coefficients of at least 0.54 (p < 0.05 to <
0.0001) were found for the agreement of telephone and
in-person scores on tests assessing the cognitive domains
of attention, memory, concentration / working memory,
reasoning, and language / crystallized intelligence. An
almost perfect correlation was observed in the assessment
of reasoning (Similarities). Substantial correlations were
found for the Digit Span, Similarities, and Vocabulary
tests (.61 to .80) and moderate correlations (.41 to .60)
were found for each Logical Memory immediate and delay
recall. A moderate correlation (0.56) was seen with the in-
person and telephone administration of the Digit-Span-
backward (concentration / working memory). Only a fair
correlation (0.28; p= 0.09) was found between the in-per-
son and telephone administration of the Hayling Sen-
tence Completion test of executive function. For Letter-
Number Sequence test (concentration/working memory)
scores were not correlated for the in-person and telephone
tests.
Stability over time was greatest for the Similarities and
Vocabulary tests. The effects of learning showed that test
scores tended to increase between the in-person and tele-
Table 3: In-person and telephone neuropsychological test scores.
Test Mean Median SD Range
Number-letter Sequencing
In-person 9.3 10 2.6 5 to 14
Telephone 9.3 9 2.5 5 to 15
Logical Memory
Immediate Recall†
In-person 24.4 23 5.9 14 to 33
Telephone 27.0 26 8.2 17 to 44
Delay Recall†
In-person 18.8 18 5.4 10 to 30
Telephone 22.0 23 7.5 6 to 34
Digit Span
In-person 11.6 11 3.2 6 to 18
Telephone 9.3 9 2.4 5 to 15
Hayling Sentence Completion 
Test
In-person 5.7 6 1.1 4 to 8
Telephone 6.6 6 0.89 6 to 10
Similarities
In-person 11.0 12 2.9 4 to 16
Telephone 10.9 10 3.1 5 to 16
Vocabulary
In-person 10.6 11 2.6 6 to 16
Telephone 11.5 11 2.6 7 to 17
All values are scaled scores (mean = 10, standard deviation = 3) except † = raw scores.
Logical memory and Number-letter sequencing are from the WMS-III; digit span, similarities and vocabulary are from the WAIS-R.Respiratory Research 2005, 6:39 http://respiratory-research.com/content/6/1/39
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phone tests, with the most improvement for verbal mem-
ory (e.g. logical memory immediate and delayed recall).
Discussion
We found the battery of well-established neurocognitive
tests to be amenable to administration by telephone and
valid for the identification of neurocognitive deficits in
patients with PAH. Testing was readily completed in a sin-
gle, 30–60 minute session, and required neither special-
ized testing facilities nor travel by physically debilitated
patients spread across a broad geographic area.
Our study was designed to validate the administration by
telephone of a battery of neurocognitive tests against the
in-person ("gold standard") performance of these same
assessments. Each of the tests in the battery has been pre-
viously validated for the identification of neurocognitive
deficits in various populations, including those with car-
diopulmonary disease-. As such, our subjects' scores
during in-person testing served as matched controls for
comparison with the results obtained upon application of
these same tests over the telephone.
The scores from telephone and in-person assessments cor-
related strongly for the majority of tests. Overall, the
strengths of the correlations with in-person testing found
here are comparable to those that we reported previously
for the same test battery applied to ARDS survivors [8] and
the correlations reported for other telephone neurocogni-
tive test batteries [21-25]. Two items in the test battery did
not correlate as well as the others. The interclass correla-
tions for the Hayling Sentence Completion test only
approached significance (p = 0.09). The in-person and tel-
ephone administrations of the Letter-Number-Sequenc-
ing component of the WMS III (a test of concentration/
working memory) did not correlate well. Some subjects
appeared to have difficulty discriminating phonetically
similar sounds (e.g. the letters 'm' and 'n') when presented
during telephone sessions; visual cues may have alleviated
such issues at in-person sessions. In contrast, another
component of the WMS III (Digits Backward) evaluating
the same cognitive domain (concentration/working
memory) had substantial correlations.
Although the correlations we found between in-person
testing and subsequent telephone administration of the
same test battery were moderate or higher, they were not
perfect. The effects of learning or practice suggest that test
scores increase between the in-person and telephone tests,
with the most improvement in verbal memory. Thus, the
improvement in test scores on the telephone administra-
tion of the test likely reflects practice effects. An alternative
explanation for the tendency of subjects to perform better
on the telephone test battery may be environmental fac-
tors. For example subjects scored higher on certain tasks
when assessed at home as compared to similar tasks per-
formed in a clinic setting [26]. Improved orientation to
time and place have been found when patients were tested
in their own residence [22]. Further, patients report less
anxiety and prefer telephone testing compared to in-per-
son evaluation [27]. In addition to the pragmatic advan-
tages, telephone testing may provide a better assessment
of patients' cognitive function in their normal environ-
ment. Finally, it is possible that neurocognitive function
Table 4: Reliability of the in-person and telephone neuropsychological test scores.
Neuropsychological 
Test
Learning Effect (Improvement 
T1 to T2 expressed in SDs)
Intraclass Correlation 95% C.I. p
Number-letter Sequencing .78 (0 to 3.1) .15 -.28 to .52 0.25
Logical Memory
Immediate Recall† 1.3 (0 to 5.0) .55 -.20 to .72 0.05
Delay Recall† 1.2 (.18 to 3.4) .54 -.24 to .82 0.05
Digit Span
Forward† .74 .41 to .90 0.0002
Backward† .56 -.24 to .84 0.05
Both .83 (0 to 1.9) .63 .29 to .83 0.0006
Hayling Sentence
Completion Test
.98 (0 to 3.8) .28 -.14 to .61 0.09
Similarities .65 (0 to 2.0) .82 .62 to .92 <0.0001
Vocabulary .53 (0 to 1.5) .68 .38 to .85 0.001
All scores shown are scaled scores (mean = 10, standard deviation = 3), except † = raw scores. Logical memory and Number-letter sequencing are 
from the WMS-III; digit span, similarities and vocabulary are from the WAIS-R.Respiratory Research 2005, 6:39 http://respiratory-research.com/content/6/1/39
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improved during the interval between the two test ses-
sions (mean 122 days). The reason for a potential
improvement in neurocognitive performance will be
important in future studies that use repeated test adminis-
tration to determine the effect of drugs for PAH or other
interventions on neurocognitive function.
An important limitation of our study was our inability to
reverse the order of administration (in-person and tele-
phone) [28]. Our subjects were enrolled in another ongo-
ing study, which required in-person assessments prior to
enrollment in this study of telephone testing [29]. An
alternative would be to repeat in-person and telephone
assessments in random order following the initial inter-
view. Such additional testing, however, might have
increased the potential for learning or practice affects, and
the further time and travel commitments for patients
likely impacting study participation. Future studies
should counterbalance the order of in-person and tele-
phone administration. Due to pragmatic limitations the
time interval between in-person and telephone testing
was somewhat longer than the minimum time necessary
to minimize recall and learning effects.
Telephone testing has been used successfully in the assess-
ment of neruocognitive impairment in other patient pop-
ulations. Further, the ease in application and relative low
cost of telephone testing have enabled assessments in sev-
eral large clinical studies of cognitive function: screening
of 4,932 elderly patients for Alzheimer's Disease using the
modified Mini-Mental State Examination for telephone
administration [30]; cognitive function in 4,023 patients
with cardiovascular risk factors [31]; 466 patients with
coronary artery bypass graft surgery [32], and in a self-
referred ARDS patient group [8]. In addition to neurocog-
nitive testing, telephone-based assessments have provided
accurate determinations of quality of life, medication
usage, 24-hour physical activity and dietary recall [33-35].
Cognitive function has not been studied in pulmonary
arterial hypertension, despite the frequent reports of prob-
lems with memory and concentration [5]. Cognitive
impairments are important complications of other
chronic and life-threatening illnesses, and are associated
with a significantly worse prognosis [36-38]. Cognitive
impairments can also profoundly reduce quality of life
[39-42]. Therapies that improve physical function in PAH
may have important (but as yet unknown) effects on neu-
rocognitive function, positive or negative. For these rea-
sons, research on neurocognitive function is warranted.
The brief neurocognitive telephone test battery is valid for
assessment of cognitive function in this population and
provides the means to pursue further, larger studies to
assess the frequency and risk factors of cognitive sequelae
in patients with PAH.
Conclusion
This study has demonstrated that scores on a battery of
neurocognitive tests obtained by telephone administra-
tion correlated well with in-person testing in patients with
pulmonary arterial hypertension. The strong correlations
observed are comparable to previous studies that assessed
in-person and telephone versions of neurocognitive tests.
With minor modification, the telephone neuropsycholog-
ical test battery described here provides an economical
and reliable method for assessing cognitive function in
patients with pulmonary arterial hypertension.
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